Regarding the concern of neutropenia, an increased incidence of bevacizumab-related neutropenia mainly occurred with the combination with cytotoxic chemotherapy, but not with EGFR-TKIs [10,11,12,15,16,17,23,24]. Here, EGFR is linked to neutropenia.